with the bullishness in pharma industry due to fda approvals(40% of us market) and lupin has bottomed out with a trend reversal,which is visible in our charts. a conversative setup for a short term
enter at around 990 with CBSL of 920 and target of 1045
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.